Drug Type Chemical drugs |
Synonyms- |
Target |
Action antagonists |
Mechanism F2R antagonists(Protease-activated receptor-1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic Nephropathies | Preclinical | United States | 08 Mar 2025 |